True to form, Wall Street has conjured up an exchange-traded fund to capitalize on a new trend. Hypochondriacs ought to keep at least 6 feet away from it. The ETFMG Treatments, Testing and Advancements ETF was listed on the NYSE Arca exchange on Wednesday. The name might not grab attention, but the chosen ticker, GERM, sure will. If the ticker...

Source: Wall Street Journal June 19, 2020 15:15 UTC